Opinion | The Covid Vaccine Windfall Turns on Pfizer and Moderna
Briefly

The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a creature from the Black Lagoon. Public-health officials indicated we'd need another updated booster. Share prices in Pfizer and Moderna surged.
In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill.
Read at WSJ
[
add
]
[
|
|
]